David Johnson
Directeur/Bestuurslid bij CARIBOU BIOSCIENCES, INC.
Vermogen: - $ op 30-04-2024
Actieve functies van David Johnson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Directeur/Bestuurslid | 11-05-2022 | - |
| Independent Dir/Board Member | 11-05-2022 | - |
Loopbaan van David Johnson
Eerdere bekende functies van David Johnson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 12-03-2018 | 01-12-2022 |
| GILEAD SCIENCES, INC. | Verkoop & Marketing | 01-01-2003 | 01-01-2018 |
Opleiding van David Johnson
| University of Puget Sound | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- David Johnson
- Ervaring
